EMR vs DOV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 05, 2026
EMR
DOV
Investment Advisor Scores
DOV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EMR | DOV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 20.4918 | 18.0505 | DOV |
| PEG Ratio | 1.6989 | 1.4546 | DOV |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.0% | 7.5% | DOV |
| Earnings Growth | 23.0% | 12.9% | EMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 53.0/100 | 33.2/100 | EMR |
| Profit Margin | 13.8% | 13.6% | EMR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | EMR |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EMR
MarkupPrice above SMA50, rising 50-day trend (1.5% over 20 days), RSI 64
DOV
NeutralMixed signals - no dominant trend phase, RSI 68
Fundamentals Snapshot
| Metric | EMR | DOV |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.5 | 18.1 |
| Trailing P/E | 36.3 | 24.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.3% | 0.2% |
| EPS | 4.58 | 8.57 |
| Dividend Yield | 0.01% | 0.01% |